Among people with substance dependence and HIV or high-risk for HIV, 64% engaged in an addiction treatment program integrated into primary care.
At 6-months after starting the program, 60% had been treated with buprenorphine and buprenorphine treatment was associated with engagement.
Self-reported depression was common and associated with persistent substance dependence at 6 months.